Emily J. Tsai, MD, FACC, FAHA
1992 Robert C. Byrd Scholarship
1992 Presidential Scholar Finalist
1996 Thomas T. Hoopes Prize, Harvard College
1996 Magna Cum Laude, Harvard College
1999 Inductee, The Aesculapian Club, Harvard Medical School
1999 Howard Hughes Medical Institute-National Institutes of Health Research Scholar
2000 Howard Hughes Medical Institute-National Institutes of Health Advanced Scholar
2001 Howard Hughes Medical Institute Continued Fellowship for Medical Studies
2001 Wellsford & Mildred Clark Medical Memorial Scholarship
2002 Cum Laude, Harvard Medical School
2007 Ruth L. Kirschstein National Research Service Award
2008 Finalist, Northwestern Cardiovascular Young Investigators’ Forum
2010 Faculty Development Research Award, Department of Medicine, Temple University
2012 Jay N. Cohn New Investigator Award in Basic Science, Heart Failure Society of America
2015 Provost's Grant for Junior Faculty Who Contribute to the Diversity Goals of the University, Columbia University
2016 M. Irene Ferrer Scholar Award, Columbia University College of P&S Department of Medicine and The Foundation for Gender-Specific Medicine
2017 Presidential Career Development Award, American College of Cardiology
Emily J. Tsai, MD, FACC, FAHA, is an Assistant Professor of Medicine in the Department of Medicine, Division of Cardiology. She is an attending physician in the Center for Advanced Cardiac Care at New York-Presbyterian Hospital at the Columbia University Irving Medical Center. Board-certified in Cardiovascular Medicine and Advanced Heart Failure and Transplant Cardiology, Dr. Tsai specializes in caring for heart failure patients who require, or have received, a ventricular assist device or heart transplant.
Dr. Tsai is a magna cum laude graduate in engineering sciences of Harvard College. She received her MD cum laude from Harvard Medical School in the Harvard-MIT Division of Health Sciences and Technology and completed her internal medicine residency training at the Hospital of the University of Pennsylvania and cardiology fellowship at The Johns Hopkins Hospital. While at Hopkins, Dr. Tsai focused her clinical training in advanced heart failure and transplant cardiology. Supported by a Ruth L. Kirschstein National Research Service Award, Dr. Tsai also completed post-doctoral basic cardiovascular research training at Johns Hopkins University in the laboratory of David A. Kass, MD, FAHA. After her post-doctoral fellowship, Dr. Tsai was recruited to Temple University School of Medicine as an assistant professor of medicine and physiology and a principal investigator in its Cardiovascular Research Center. In 2015, Dr. Tsai joined the faculty of Columbia University College of Physicians & Surgeons.
Dr. Tsai is a physician-scientist who focuses on the molecular mechanisms of heart failure, specifically the dysregulation of nitric oxide signaling within heart cells and the pathobiology of right ventricular dysfunction. A translational investigator, Dr. Tsai also analyzes biological samples of heart failure patients to direct mechanistic studies in animal models. The ultimate goal of the Tsai laboratory is to discover novel approaches for the treatment of chronic heart failure, with an emphesis on preventing and reversing right ventricular failure. The Tsai lab is also interested in gender differences in the molecular signaling of heart failure. Dr. Tsai has received national recognition for her research accomplishments. Her research awards include the 2017 American College of Cardiology Presidential Career Development Award, the inaugural 2016 M. Irene Ferrer Scholar Award, the 2015 Columbia University Provost's Grant for Junior Faculty Who Contribute to the Diversity Goals of the University, and the 2012 Jay N. Cohn New Investigator Award in Basic Science from the Heart Failure Society of America. Dr. Tsai has received numerous research grants including the NHLBI K08 Career Development Award, an NHLBI R03, and the AHA National Scientist Development Grant.
Dr. Tsai reviews grants for the American Heart Association and is an author of the 2013 ACCF/AHA Guideline for the Management of Heart Failure.